150 related articles for article (PubMed ID: 19930272)
1. Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients.
Epaulard O; Saint-Raymond C; Villier C; Charles J; Roch N; Beani JC; Leccia MT
Clin Microbiol Infect; 2010 Sep; 16(9):1362-4. PubMed ID: 19930272
[TBL] [Abstract][Full Text] [Related]
2. Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole.
Feist A; Lee R; Osborne S; Lane J; Yung G
J Heart Lung Transplant; 2012 Nov; 31(11):1177-81. PubMed ID: 22841559
[TBL] [Abstract][Full Text] [Related]
3. Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients.
Vadnerkar A; Nguyen MH; Mitsani D; Crespo M; Pilewski J; Toyoda Y; Bermudez C; Kwak EJ; Silveira FP; Clancy CJ
J Heart Lung Transplant; 2010 Nov; 29(11):1240-4. PubMed ID: 20591690
[TBL] [Abstract][Full Text] [Related]
4. Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy.
McCarthy KL; Playford EG; Looke DF; Whitby M
Clin Infect Dis; 2007 Mar; 44(5):e55-6. PubMed ID: 17278050
[TBL] [Abstract][Full Text] [Related]
5. Phototoxicity and photocarcinogenesis associated with voriconazole.
Epaulard O; Leccia MT; Blanche S; Chosidow O; Mamzer-Bruneel MF; Ravaud P; Thiebaut A; Villier C; Lortholary O
Med Mal Infect; 2011 Dec; 41(12):639-45. PubMed ID: 22055586
[TBL] [Abstract][Full Text] [Related]
6. Multifocal squamous cell carcinomas in an HIV-infected patient with a long-term voriconazole therapy.
Brunel AS; Fraisse T; Lechiche C; Pinzani V; Mauboussin JM; Sotto A
AIDS; 2008 Apr; 22(7):905-6. PubMed ID: 18427212
[No Abstract] [Full Text] [Related]
7. Pseudoporphyria associated with voriconazole.
Kwong WT; Hsu S
J Drugs Dermatol; 2007 Oct; 6(10):1042-4. PubMed ID: 17966183
[TBL] [Abstract][Full Text] [Related]
8. High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients.
Singer JP; Boker A; Metchnikoff C; Binstock M; Boettger R; Golden JA; Glidden DV; Arron ST
J Heart Lung Transplant; 2012 Jul; 31(7):694-9. PubMed ID: 22484291
[TBL] [Abstract][Full Text] [Related]
9. Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole.
Cowen EW; Nguyen JC; Miller DD; McShane D; Arron ST; Prose NS; Turner ML; Fox LP
J Am Acad Dermatol; 2010 Jan; 62(1):31-37. PubMed ID: 19896749
[TBL] [Abstract][Full Text] [Related]
10. Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation.
Zwald FO; Spratt M; Lemos BD; Veledar E; Lawrence C; Marshall Lyon G; Chen SC
Dermatol Surg; 2012 Aug; 38(8):1369-74. PubMed ID: 22551390
[TBL] [Abstract][Full Text] [Related]
11. Photosensitivity in immunocompromised patients receiving long-term therapy with oral voriconazole.
Frick MA; Soler-Palacín P; Martín Nalda A; Guarner ME; Nadal CF
Pediatr Infect Dis J; 2010 May; 29(5):480-1. PubMed ID: 20431387
[No Abstract] [Full Text] [Related]
12. Voriconazole-associated phototoxicity.
Riahi RR; Cohen PR
Dermatol Online J; 2011 Feb; 17(2):15. PubMed ID: 21382298
[TBL] [Abstract][Full Text] [Related]
13. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
Vehreschild JJ; Böhme A; Buchheidt D; Arenz D; Harnischmacher U; Heussel CP; Ullmann AJ; Mousset S; Hummel M; Frommolt P; Wassmer G; Drzisga I; Cornely OA
J Infect; 2007 Nov; 55(5):445-9. PubMed ID: 17822770
[TBL] [Abstract][Full Text] [Related]
14. [Careful: skins cancers and voriconazole].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2011 Nov; 138(11):805-6. PubMed ID: 22078051
[No Abstract] [Full Text] [Related]
15. Severe phototoxicity associated with long-term voriconazole treatment.
Vöhringer S; Schrum J; Ott H; Höger PH
J Dtsch Dermatol Ges; 2011 Apr; 9(4):274-6. PubMed ID: 21050383
[TBL] [Abstract][Full Text] [Related]
16. Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy.
Wermers RA; Cooper K; Razonable RR; Deziel PJ; Whitford GM; Kremers WK; Moyer TP
Clin Infect Dis; 2011 Mar; 52(5):604-11. PubMed ID: 21239842
[TBL] [Abstract][Full Text] [Related]
17. Voriconazole-induced photosensitivity.
Malani AN; Aronoff DM
Clin Med Res; 2008 Sep; 6(2):83-5. PubMed ID: 18801950
[TBL] [Abstract][Full Text] [Related]
18. Torsades de pointes associated with voriconazole use.
Philips JA; Marty FM; Stone RM; Koplan BA; Katz JT; Baden LR
Transpl Infect Dis; 2007 Mar; 9(1):33-6. PubMed ID: 17313469
[TBL] [Abstract][Full Text] [Related]
19. Painful peripheral neuropathy associated with voriconazole use.
Tsiodras S; Zafiropoulou R; Kanta E; Demponeras C; Karandreas N; Manesis EK
Arch Neurol; 2005 Jan; 62(1):144-6. PubMed ID: 15642862
[TBL] [Abstract][Full Text] [Related]
20. The role of voriconazole in the treatment of central nervous system blastomycosis.
Ta M; Flowers SA; Rogers PD
Ann Pharmacother; 2009 Oct; 43(10):1696-700. PubMed ID: 19724015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
